Nrx Pharmaceuticals Stock Price Prediction
| NRXP Stock | USD 3.02 1.16 27.75% |
Oversold Vs Overbought
52
Oversold | Overbought |
NRX Pharmaceuticals stock price prediction is an act of determining the future value of NRX Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of NRX Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of NRX Pharmaceuticals and does not consider all of the tangible or intangible factors available from NRX Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with NRX Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of NRX Pharmaceuticals based on different types of headlines from major news networks to social media. The NRX stock price prediction module provides an analysis of price elasticity to changes in media outlook on NRX Pharmaceuticals over a specific investment horizon. Using NRX Pharmaceuticals hype-based prediction, you can estimate the value of NRX Pharmaceuticals from the perspective of NRX Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in NRX Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in NRX Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying NRX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NRX Pharmaceuticals after-hype prediction price | USD 6.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NRX |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NRX Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NRX Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of NRX Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NRX Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NRX Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NRX Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting NRX Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NRX Pharmaceuticals' historical news coverage. NRX Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.31 and 16.23, respectively. We have considered NRX Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NRX Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of NRX Pharmaceuticals is based on 3 months time horizon.
NRX Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as NRX Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NRX Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NRX Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 10.56 | 0.00 | 0.00 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.02 | 4.83 | 60.00 |
|
NRX Pharmaceuticals Hype Timeline
NRX Pharmaceuticals is now traded for 3.02. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. NRX is anticipated to increase in value after the next headline, with the price projected to jump to 4.832 or above. The average volatility of media hype impact on the company the price is insignificant. The price gain on the next news is projected to be 60.0%, whereas the daily expected return is now at 0.0%. The volatility of related hype on NRX Pharmaceuticals is about 195834.52%, with the expected price after the next announcement by competition of 3.02. The company currently holds 9.16 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. NRX Pharmaceuticals has a current ratio of 4.49, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist NRX Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, NRX Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NRX Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NRX to invest in growth at high rates of return. When we think about NRX Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next anticipated press release will be uncertain. Check out NRX Pharmaceuticals Basic Forecasting Models to cross-verify your projections.NRX Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to NRX Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict NRX Pharmaceuticals' future price movements. Getting to know how NRX Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NRX Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RLFFD | Relief Therapeutics Holding | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PHGE | Biomx Inc | 0.01 | 8 per month | 7.63 | 0.08 | 9.52 | (8.89) | 242.03 | |
| LEXX | Lexaria Bioscience Corp | 0.00 | 0 per month | 8.49 | 0.10 | 17.65 | (12.82) | 68.41 | |
| ADTX | Aditxt Inc | 0.00 | 0 per month | 0.00 | (0.16) | 5.97 | (8.31) | 24.80 | |
| NTRB | Nutriband | 0.00 | 0 per month | 4.21 | 0.13 | 9.76 | (6.72) | 44.56 | |
| QNRX | Quoin Pharmaceuticals Ltd | (0.11) | 8 per month | 0.00 | (0.34) | 4.69 | (9.67) | 53.64 | |
| LGVN | Longeveron LLC | 0.00 | 0 per month | 0.00 | (0.13) | 8.37 | (18.80) | 114.17 | |
| RNXT | RenovoRx | 0.00 | 0 per month | 5.58 | 0.04 | 12.78 | (7.78) | 42.62 | |
| VRAX | Virax Biolabs Group | 0.04 | 2 per month | 0.00 | (0.13) | 6.15 | (6.54) | 27.96 | |
| SABSW | SAB Biotherapeutics | (0.0001) | 3 per month | 11.81 | 0.04 | 42.86 | (21.15) | 174.45 | |
| SNTI | Senti Biosciences | 0.00 | 0 per month | 0.00 | (0.1) | 7.50 | (8.11) | 26.47 | |
| CING | Cingulate | 0.00 | 0 per month | 0.00 | (0.18) | 11.01 | (15.22) | 82.61 | |
| HILS | Hillstream Biopharma | (0.01) | 2 per month | 0.00 | (0.14) | 7.89 | (8.33) | 24.20 |
NRX Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine NRX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NRX using various technical indicators. When you analyze NRX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NRX Pharmaceuticals Predictive Indicators
The successful prediction of NRX Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NRX Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NRX Pharmaceuticals based on analysis of NRX Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NRX Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NRX Pharmaceuticals's related companies. Story Coverage note for NRX Pharmaceuticals
The number of cover stories for NRX Pharmaceuticals depends on current market conditions and NRX Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NRX Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NRX Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
NRX Pharmaceuticals Short Properties
NRX Pharmaceuticals' future price predictability will typically decrease when NRX Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NRX Pharmaceuticals often depends not only on the future outlook of the potential NRX Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NRX Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.6 M | |
| Cash And Short Term Investments | 4.6 M |
Check out NRX Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for NRX Stock analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is NRX Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NRX Pharmaceuticals. If investors know NRX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NRX Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NRX Pharmaceuticals is measured differently than its book value, which is the value of NRX that is recorded on the company's balance sheet. Investors also form their own opinion of NRX Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NRX Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NRX Pharmaceuticals' market value can be influenced by many factors that don't directly affect NRX Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NRX Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NRX Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NRX Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.